Valvular & structural heart diseaseCohort study

Atrial Functional Mitral Regurgitation Subtypes Undergoing Transcatheter Edge-to-Edge Repair

JACC Cardiovasc ImagingPublished

  • Retrospective cohort study
  • consecutive patients

Authors' conclusion

AFMR-AH shows worse procedural and clinical outcomes following M-TEER than AFMR-IAD.

Study context

Population
Patients with atrial functional mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair (M-TEER)of 1,047 M-TEER patients
Participants
128 patients
Exposure
AFMR-AH vs AFMR-IAD undergoing M-TEER
  • AFMR-AHn = 53
  • AFMR-IADn = 75reference

Main finding

As reported in the abstract

Procedural failure (30 days) and all-cause mortality (1 year)

AFMR-AH

43.4%

Procedural failure at 30 days · Kaplan-Meier estimated 1-year survival 77%

AFMR-IAD

24.0%

Procedural failure at 30 days · Kaplan-Meier estimated 1-year survival 92%

AFMR-AH vs AFMR-IADEstimate (95% CI)P value
procedural failure at 30 days; 43.4% vs 24.0%, P = 0.023
OR 1.17(1.00–1.38)
P = 0.045
all-cause mortality at 1 year; survival 77% vs 92%, P = 0.017
HR 2.54(1.09–5.91)
P = 0.031

Observational data: associations, not effects.

Further findings

Technical success

MR ≤II · 30 days and 1 year

30 days

1 year

  • Technical success: P = 0.009
  • MR ≤II: 30 days P = 0.009
  • MR ≤II: 1 year P = 0.038

Baseline echocardiography

AFMR-AH: greater LA and LV volumes, greater mitral annulus, shorter and steeper posterior leaflet, more pronounced MR
all P < 0.05

Safety

OutcomeAFMR-IADAFMR-AH
Device detachment at dischargeNot reported in the abstract10.0%

Device detachment at discharge

Observed exclusively in AFMR-AH

Original publication

Atrial Functional Mitral Regurgitation Subtypes Undergoing Transcatheter Edge-to-Edge Repair. JACC Cardiovasc Imaging. Published 28 August 2024. doi:10.1016/j.jcmg.2024.06.019

Summarised from the published abstract; every number is checked against it